TALACOTUZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

TALACOTUZUMAB

Official Name

English

talacotuzumab [INN]

Common Name

English

CSL-362

Code

English

IMMUNOGLOBULIN G1-2-KAPPA, ANTI-(HOMO SAPIENS IL3RA (INTERLEUKIN 3 RECEPTOR SUBUNIT ALPHA, INTERLEUKIN 3 RECEPTOR ALPHA (LOW AFFINITY), CD123)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1-2 HEAVY CHAIN (1-450) (HUMANIZED VH (HOMO SAPIENS IGHV5-51*01 (82.70%) -(

Common Name

English

ANTI-IL-3 RECEPTOR ALPHA MONOCLONAL ANTIBODY CSL362

Common Name

English

Talacotuzumab [WHO-DD]

Common Name

English

JNJ-56022473

Code

English

CSL362

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

FDA ORPHAN DRUG

478715

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

NCI_THESAURUS

C129822

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

Code System Code Type Description

CAS

1826831-79-1

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

PRIMARY

NCI_THESAURUS

C102784

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

PRIMARY

INN

10508

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

PRIMARY

FDA UNII

X8JR0I7JE1

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

PRIMARY

DRUG BANK

DB14796

Created by admin on Sat Dec 16 13:54:35 GMT 2023 , Edited by admin on Sat Dec 16 13:54:35 GMT 2023

PRIMARY

ACTIVE MOIETY


					X8JR0I7JE1